Literature DB >> 8203517

Liver glycogen turnover in fed and fasted humans.

I Magnusson1, D L Rothman, B Jucker, G W Cline, R G Shulman, G I Shulman.   

Abstract

Whether liver glycogen synthesis and breakdown occur simultaneously during net glycogen synthesis was assessed in fed and fasted healthy humans. The peak intensity of the carbon-1 (C1) resonance of the glycosyl units of glycogen was monitored with 13C nuclear magnetic resonance spectroscopy during [1-13C]glucose infusion followed by unlabeled glucose infusion. The C1 peak intensity increased almost linearly during the [1-13C]glucose infusion, reflecting a near linear rate of glycogen synthesis. When switched to unlabeled glucose, the C1 peak intensity reached a plateau in the fasted subjects and declined in the fed subjects, reflecting active glycogenolysis during a time of net glycogen synthesis. We conclude that liver glycogen synthesis and degradation occur simultaneously in humans under conditions of net glycogen synthesis. The relative turnover rate was significantly higher in the fed (57 +/- 3%) than in the fasted state (31 +/- 8%; P < 0.01). The results indicate that glycogen may regulate its rate of breakdown and that liver glycogen turnover may be an important factor in limiting the accumulation of liver glycogen in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203517     DOI: 10.1152/ajpendo.1994.266.5.E796

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  31 in total

1.  Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.

Authors:  M K Hellerstein; R A Neese; P Linfoot; M Christiansen; S Turner; A Letscher
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  The use of magnetic resonance methods in translational cardiovascular research.

Authors:  Arthur H L From; Kamil Ugurbil
Journal:  J Cardiovasc Transl Res       Date:  2009-01-13       Impact factor: 4.132

3.  Insulin:Carbohydrate Ratio--Part of the Story.

Authors:  Ananda Basu; Rita Basu
Journal:  Diabetes Technol Ther       Date:  2015-12       Impact factor: 6.118

4.  Computational model of in vivo human energy metabolism during semistarvation and refeeding.

Authors:  Kevin D Hall
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01-31       Impact factor: 4.310

5.  Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.

Authors:  K F Petersen; D Laurent; D L Rothman; G W Cline; G I Shulman
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

6.  Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects.

Authors:  G Velho; K F Petersen; G Perseghin; J H Hwang; D L Rothman; M E Pueyo; G W Cline; P Froguel; G I Shulman
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

7.  Glucose-1-phosphate utilization by Listeria monocytogenes is PrfA dependent and coordinately expressed with virulence factors.

Authors:  M T Ripio; K Brehm; M Lara; M Suárez; J A Vázquez-Boland
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

Review 8.  Nuclear magnetic resonance studies of glucose metabolism in non-insulin-dependent diabetes mellitus subjects.

Authors:  R G Shulman
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

9.  Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.

Authors:  Wojciech G Garbacz; Peipei Lu; Tricia M Miller; Samuel M Poloyac; Nicholas S Eyre; Graham Mayrhofer; Meishu Xu; Songrong Ren; Wen Xie
Journal:  Mol Cell Biol       Date:  2016-10-13       Impact factor: 4.272

10.  Predicting metabolic adaptation, body weight change, and energy intake in humans.

Authors:  Kevin D Hall
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.